GUARDANT HEALTH, INC. Payments to Acquire Debt Securities, Available-for-sale
GUARDANT HEALTH, INC. (GH) reported Payments to Acquire Debt Securities, Available-for-sale of $249.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-07-30
- GUARDANT HEALTH, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $0.00.
- GUARDANT HEALTH, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $249.94M.
- GUARDANT HEALTH, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $818.23M.
- GUARDANT HEALTH, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- GUARDANT HEALTH, INC. payments to acquire debt securities, available-for-sale for fiscal 2025 was $818.23M, a 166.24% increase from fiscal 2024.
- GUARDANT HEALTH, INC. payments to acquire debt securities, available-for-sale for fiscal 2024 was $307.32M, a 51.21% decline from fiscal 2023.
- GUARDANT HEALTH, INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $629.90M, a 107.37% increase from fiscal 2022.
- GUARDANT HEALTH, INC. payments to acquire debt securities, available-for-sale for fiscal 2022 was $303.76M, a 66.28% decline from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $249.94M 10-Q · filed 2026-07-30 | $1.07B derived: sum of 3 quarters · filed 2026-07-30 | $1.07B derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $249.94M 10-Q · filed 2026-05-07 | $1.07B derived: sum of 2 quarters · filed 2026-05-07 | $1.07B derived: sum of 3 quarters · filed 2026-05-07 | $1.07B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $818.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $818.23M derived: sum of 2 quarters · filed 2026-02-19 | $818.23M derived: sum of 3 quarters · filed 2026-07-30 | $818.23M 10-K · filed 2026-02-19 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2026-07-30 | $0.00 10-Q · filed 2025-10-29 | $0.00 derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $0.00 10-Q · filed 2026-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-07-30 | $307.32M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $307.32M derived: sum of 3 quarters · filed 2026-05-07 | $307.32M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $307.32M derived: sum of 2 quarters · filed 2026-02-19 | $307.32M derived: sum of 3 quarters · filed 2026-02-19 | $307.32M 10-K · filed 2026-02-19 |
| 2024-09-30 | $307.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $307.32M derived: sum of 2 quarters · filed 2025-10-29 | $307.32M 10-Q · filed 2025-10-29 | $307.32M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $68.56M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $68.56M derived: sum of 3 quarters · filed 2026-02-19 | $566.65M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $68.56M derived: sum of 2 quarters · filed 2026-02-19 | $566.65M derived: sum of 3 quarters · filed 2026-02-19 | $629.90M 10-K · filed 2026-02-19 |
| 2023-09-30 | $68.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $566.65M derived: sum of 2 quarters · filed 2024-11-06 | $629.90M 10-Q · filed 2024-11-06 | $695.06M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $498.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $561.34M 10-Q · filed 2024-08-07 | $626.50M derived: sum of 3 quarters · filed 2025-02-20 | $626.50M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $63.25M 10-Q · filed 2024-05-09 | $128.41M derived: sum of 2 quarters · filed 2025-02-20 | $128.41M derived: sum of 3 quarters · filed 2025-02-20 | $203.27M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $65.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $65.16M derived: sum of 2 quarters · filed 2025-02-20 | $140.01M derived: sum of 3 quarters · filed 2025-02-20 | $303.76M 10-K · filed 2025-02-20 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $74.86M derived: sum of 2 quarters · filed 2023-11-06 | $238.60M 10-Q · filed 2023-11-06 | $805.33M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $74.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $238.60M 10-Q · filed 2023-08-03 | $805.33M derived: sum of 3 quarters · filed 2024-02-22 | |
| 2022-03-31 | $163.74M 10-Q · filed 2023-05-09 | $730.47M derived: sum of 2 quarters · filed 2024-02-22 | ||
| 2021-12-31 | $566.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $900.81M 10-K · filed 2024-02-22 | ||
| 2021-09-30 | $334.08M 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |